Explore the vast range of titles available.

A reduction in crop productivity in cultivable land and challenging environmental factors have directed advancement in indoor cultivation systems, such that the yield parameters are higher in outdoor cultivation systems. In wake of this situation, light emitting diode (LED) lighting has proved to be promising in the field of agricultural lighting. Properties such as energy efficiency, long lifetime, photon flux efficacy and flexibility in application make LEDs better suited for future agricultural lighting systems over traditional lighting systems. Different LED spectrums have varied effects on the morphogenesis and photosynthetic responses in plants. LEDs have a profound effect on plant growth and development and also control key physiological processes such as phototropism, the immigration of chloroplasts, day/night period control and the opening/closing of stomata. Moreover, the synthesis of bioactive compounds and antioxidants on exposure to LED spectrum also provides information on the possible regulation of antioxidative defense genes to protect the cells from oxidative damage. Similarly, LEDs are also seen to escalate the nutrient metabolism in plants and flower initiation, thus improving the quality of the crops as well. However, the complete management of the irradiance and wavelength is the key to maximize the economic efficacy of crop production, quality, and the nutrition potential of plants grown in controlled environments. This review aims to summarize the various advancements made in the area of LED technology in agriculture, focusing on key processes such as morphological changes, photosynthetic activity, nutrient metabolism, antioxidant capacity and flowering in plants. Emphasis is also made on the variation in activities of different LED spectra between different plant species. In addition, research gaps and future perspectives are also discussed of this emerging multidisciplinary field of research and its development.

Heat-related illnesses, which range from heat exhaustion to heatstroke, affect thousands of individuals worldwide every year and are characterized by extreme hyperthermia with the core body temperature (CBT) usually > 40 °C, decline in physical and athletic performance, CNS dysfunction, and, eventually, multiorgan failure. The measurement of CBT has been shown to predict heat-related illness and its severity, but the current measurement methods are not practical for use in high acuity and high motion settings due to their invasive and obstructive nature or excessive costs. Noninvasive predictions of CBT using wearable technology and predictive algorithms offer the potential for continuous CBT monitoring and early intervention to prevent HRI in athletic, military, and intense work environments. Thus far, there has been a lack of peer-reviewed literature assessing the efficacy of wearable devices and predictive analytics to predict CBT to mitigate heat-related illness. This systematic review identified 20 studies representing a total of 25 distinct algorithms to predict the core body temperature using wearable technology. While a high accuracy in prediction was noted, with 17 out of 18 algorithms meeting the clinical validity standards. few algorithms incorporated individual and environmental data into their core body temperature prediction algorithms, despite the known impact of individual health and situational and environmental factors on CBT. Robust machine learning methods offer the ability to develop more accurate, reliable, and personalized CBT prediction algorithms using wearable devices by including additional data on user characteristics, workout intensity, and the surrounding environment. The integration and interoperability of CBT prediction algorithms with existing heat-related illness prevention and treatment tools, including heat indices such as the WBGT, athlete management systems, and electronic medical records, will further prevent HRI and increase the availability and speed of data access during critical heat events, improving the clinical decision-making process for athletic trainers and physicians, sports scientists, employers, and military officers.

•We propose a new framework to assess neural dynamics involved in heartbeat control.•The modeling is based on coupled synthetic data generators of EEG and RR series.•Cardiac sympathovagal activity is modelled through Laguerre expansions of RR series.•Time-varying directional brain-heart interplay is quantified under thermal stress. The study of functional Brain-Heart Interplay (BHI) from non-invasive recordings has gained much interest in recent years. Previous endeavors aimed at understanding how the two dynamical systems exchange information, providing novel holistic biomarkers and important insights on essential cognitive aspects and neural system functioning. However, the interplay between cardiac sympathovagal and cortical oscillations still has much room for further investigation. In this study, we introduce a new computational framework for a functional BHI assessment, namely the Sympatho-Vagal Synthetic Data Generation Model, combining cortical (electroencephalography, EEG) and peripheral (cardiac sympathovagal) neural dynamics. The causal, bidirectional neural control on heartbeat dynamics was quantified on data gathered from 26 human volunteers undergoing a cold-pressor test. Results show that thermal stress induces heart-to-brain functional interplay sustained by EEG oscillations in the delta and gamma bands, primarily originating from sympathetic activity, whereas brain-to-heart interplay originates over central brain regions through sympathovagal control. The proposed methodology provides a viable computational tool for the functional assessment of the causal interplay between cortical and cardiac neural control.

Effective coordination of cellular processes is critical to ensure the competitive growth of microbial organisms. Pivotal to this coordination is the appropriate partitioning of cellular resources between protein synthesis via translation and the metabolism needed to sustain it. Here, we extend a low-dimensional allocation model to describe the dynamic regulation of this resource partitioning. At the core of this regulation is the optimal coordination of metabolic and translational fluxes, mechanistically achieved via the perception of charged- and uncharged-tRNA turnover. An extensive comparison with ≈ 60 data sets from Escherichia coli establishes this regulatory mechanism’s biological veracity and demonstrates that a remarkably wide range of growth phenomena in and out of steady state can be predicted with quantitative accuracy. This predictive power, achieved with only a few biological parameters, cements the preeminent importance of optimal flux regulation across conditions and establishes low-dimensional allocation models as an ideal physiological framework to interrogate the dynamics of growth, competition, and adaptation in complex and ever-changing environments.

Human-centricity, a cornerstone of Industry 5.0, emphasizes the central role of human needs and capabilities in the technological landscape of modern manufacturing. As Digital Twins (DTs) become a core technology of Industry 4.0, the evolution towards Human Digital Twins (HDTs) marks a significant shift to enhance human-system integration. HDTs serve as digital replicas that mirror human characteristics directly in system design and performance, facilitating a more nuanced approach to smart manufacturing. This paper addresses the critical need for deeper investigation into HDTs to fully leverage their potential in promoting human-centric manufacturing. Through a comprehensive review, the current state and rapid evolution of HDT frameworks and architectures within Industry 5.0 settings are explored. The enabling technologies that underpin HDTs, their applications across various industrial scenarios, and the challenges in their development are discussed. The analysis not only underscores the importance of HDTs in meeting the diverse needs of workers but also outlines future research directions to further empower individuals within the adaptive and intelligent manufacturing systems shaped by Industry 5.0.

Background: Artificial Intelligence (AI) is increasingly applied in endurance sports to optimize performance, enhance recovery, and personalize nutrition and supplementation. This review synthesizes current knowledge on AI applications in endurance sports, emphasizing implications for metabolic health, nutritional strategies, and recovery optimization, while also addressing ethical considerations and future directions. Methods: A narrative review was conducted using targeted searches of PubMed, Scopus, and Web of Science with cross-referencing. Extracted items included sport/context, data sources, AI methods including machine learning (ML), validation type (internal vs. external/field), performance metrics, comparators, and key limitations to support a structured synthesis; no formal risk-of-bias assessment or meta-analysis was undertaken due to heterogeneity. Results: AI systems effectively integrate multimodal physiological, environmental, and behavioral data to enhance metabolic health monitoring, predict recovery states, and personalize nutrition. Continuous glucose monitoring combined with AI algorithms allows precise carbohydrate management during prolonged events, improving performance outcomes. AI-driven supplementation strategies, informed by genetic polymorphisms and individual metabolic responses, have demonstrated enhanced ergogenic effectiveness. However, significant challenges persist, including measurement validity and reliability of sensor-derived signals and overall dataset quality (e.g., noise, missingness, labeling error), model performance and generalizability, algorithmic transparency, and equitable access. Furthermore, limited generalizability due to homogenous training datasets restricts widespread applicability across diverse athletic populations. Conclusions: The integration of AI in endurance sports offers substantial promise for improving performance, recovery, and nutritional strategies through personalized approaches. Realizing this potential requires addressing existing limitations in model performance and generalizability, ethical transparency, and equitable accessibility. Future research should prioritize diverse, representative, multi-site data collection across sex/gender, age, and race/ethnicity. Coverage should include performance level (elite to recreational), sport discipline, environmental conditions (e.g., heat, altitude), and device platforms (multi-vendor/multi-sensor). Equally important are rigorous external and field validation, transparent and explainable deployment with appropriate governance, and equitable access to ensure scientifically robust, ethically sound, and practically relevant AI solutions.

Quantitative systems pharmacology (QSP) is an important approach in pharmaceutical research and development that facilitates in silico generation of quantitative mechanistic hypotheses and enables in silico trials. As demonstrated by applications from numerous industry groups and interest from regulatory authorities, QSP is becoming an increasingly critical component in clinical drug development. With rapidly evolving computational tools and methods, QSP modeling has achieved important progress in pharmaceutical research and development, including for heart failure (HF). However, various challenges exist in the QSP modeling and clinical characterization of HF. Machine/deep learning (ML/DL) methods have had success in a wide variety of fields and disciplines. They provide data-driven approaches in HF diagnosis and modeling, and offer a novel strategy to inform QSP model development and calibration. The combination of ML/DL and QSP modeling becomes an emergent direction in the understanding of HF and clinical development new therapies. In this work, we review the current status and achievement in QSP and ML/DL for HF, and discuss remaining challenges and future perspectives in the field.

Spontaneous beat-to-beat variations of heart rate (HR) have intrigued scientists and casual observers for centuries; however, it was not until the 1970s that investigators began to apply engineering tools to the analysis of these variations, fostering the field we now know as heart rate variability or HRV. Since then, the field has exploded to not only include a wide variety of traditional linear time and frequency domain applications for the HR signal, but also more complex linear models that include additional physiological parameters such as respiration, arterial blood pressure, central venous pressure and autonomic nerve signals. Most recently, the field has branched out to address the nonlinear components of many physiological processes, the complexity of the systems being studied and the important issue of specificity for when these tools are applied to individuals. When the impact of all these developments are combined, it seems likely that the field of HRV will soon begin to realize its potential as an important component of the toolbox used for diagnosis and therapy of patients in the clinic. This article is part of the theme issue ’Advanced computation in cardiovascular physiology: new challenges and opportunities’.

Advances in functional magnetic resonance imaging (fMRI) acquisition have improved signal to noise to the point where the physiology of the subject is the dominant noise source in resting state fMRI data (rsfMRI). Among these systemic, non-neuronal physiological signals, respiration and to some degree cardiac fluctuations can be removed through modeling, or in the case of newer, faster acquisitions such as simultaneous multislice acquisition, simple spectral filtering. However, significant low frequency physiological oscillation (∼0.01-0.15 Hz) remains in the signal. This is problematic, as it is the precise frequency band occupied by the neuronally modulated hemodynamic responses used to study brain connectivity, precluding its removal by spectral filtering. The source of this signal, and its method of production and propagation in the body, have not been conclusively determined. Here, we summarize the defining characteristics of the systemic low frequency noise signal, and review some current theories about the signal source and the evidence supporting them. The strength and distribution of the systemic LFO signal make characterizing and removing it essential for accurate quantification, especially for resting state connectivity, when no stimulation can be compared with the signal. Widespread correlated non-neuronal signals obscure and distort the more localized patterns of neuronal correlations between interacting brain regions; they may even cause apparent connectivity between regions with no neuronal interaction. Here, we discuss a simple method we have developed to parse the global, moving, blood-borne signal from the stationary, neuronal connectivity signals, substantially reducing the negative correlations that result from global signal regression. Finally, we will discuss some of the uses to which the moving systemic low frequency oscillation can be put if we consider it a \"signal\" carrying information, rather than simply \"noise\" complicating the interpretation of resting state connectivity. Properly utilizing this signal may offer insights into subtle hemodynamic alterations that can be used as early indicators of circulatory dysfunction in a number of neuropsychiatric conditions, such as prodromal stroke, moyamoya, and Alzheimer's disease.

Background Individualised optimisation of mechanical ventilation (MV) remains cumbersome in modern intensive care medicine. Computerised, model-based support systems could help in tailoring MV settings to the complex interactions between MV and the individual patient's pathophysiology. Therefore, we critically appraised the current literature on computational physiological models (CPMs) for individualised MV in the ICU with a focus on quality, availability, and clinical readiness. Methods A systematic literature search was conducted on 13 February 2023 in MEDLINE ALL, Embase, Scopus and Web of Science to identify original research articles describing CPMs for individualised MV in the ICU. The modelled physiological phenomena, clinical applications, and level of readiness were extracted. The quality of model design reporting and validation was assessed based on American Society of Mechanical Engineers (ASME) standards. Results Out of 6,333 unique publications, 149 publications were included. CPMs emerged since the 1970s with increasing levels of readiness. A total of 131 articles (88%) modelled lung mechanics, mainly for lung-protective ventilation. Gas exchange ( n  = 38, 26%) and gas homeostasis ( n  = 36, 24%) models had mainly applications in controlling oxygenation and ventilation. Respiratory muscle function models for diaphragm-protective ventilation emerged recently ( n  = 3, 2%). Three randomised controlled trials were initiated, applying the Beacon and CURE Soft models for gas exchange and PEEP optimisation. Overall, model design and quality were reported unsatisfactory in 93% and 21% of the articles, respectively. Conclusion CPMs are advancing towards clinical application as an explainable tool to optimise individualised MV. To promote clinical application, dedicated standards for quality assessment and model reporting are essential. Trial registration number PROSPERO— CRD42022301715 . Registered 05 February, 2022.